Page 1 of Clinical Trials for Severe Alzheimers Disease, 73 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
Last Updated: March 19, 2009
Condition(s): Moderate to Severe Alzheimer's Disease
2
Completed
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: April 25, 2010
Condition(s): Alzheimer's Disease
3
Completed
A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
Last Updated: April 22, 2011
Condition(s): Alzheimer Disease
4
Terminated
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
Last Updated: July 7, 2008
Condition(s): Severe Alzheimer's Disease
5
Completed
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
Last Updated: March 1, 2012
Condition(s): Alzheimer's Disease
6
Completed
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Last Updated: August 2, 2010
Condition(s): Mild to Severe Alzheimer's Disease
7
Completed
Memantine for Agitation and Aggression in Severe Alzheimer's Disease
Last Updated: May 24, 2012
Condition(s): Alzheimer's Disease
8
Completed
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: October 28, 2011
Condition(s): Alzheimer's Disease
9
Terminated
A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: May 14, 2010
Condition(s): Moderate to Severe Alzheimer
10
Terminated
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
Last Updated: September 8, 2011
Condition(s): Alzheimer's Disease
11
Recruiting
A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Last Updated: February 23, 2012
Condition(s): Alzheimer's Type Dementia
12
Recruiting
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Last Updated: March 5, 2012
Condition(s): Alzheimer's Type Dementia
13
Completed
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Last Updated: March 31, 2011
Condition(s): Alzheimer's Disease; Dementia
14
Completed
Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
Last Updated: June 7, 2011
Condition(s): Dementia; Alzheimer Disease
15
Terminated
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Last Updated: September 8, 2011
Condition(s): Alzheimer Disease
16
Completed
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
Last Updated: August 25, 2010
Condition(s): Dementia of the Alzheimer's Type
17
Completed
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Last Updated: November 17, 2010
Condition(s): Alzheimer's Disease
18
Active, not recruiting
A Double-blind, Placebo-controlled, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease.
Last Updated: May 21, 2012
Condition(s): Alzheimer Disease; Dementia, Alzheimer Type
19
Terminated
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Last Updated: January 17, 2012
Condition(s): Alzheimer's Disease
20
Completed
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: March 1, 2012
Condition(s): Alzheimer's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Severe+Alzheimers+Disease

Page 1 of Clinical Trials for Severe Alzheimers Disease, 73 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About